EFTA01733939

ti,901.000 1. 8V1 HARRY FISCH. M.D. tel: (212) 879-0800 fax: (212) 988-1634 FACSIMILE TRANSMISSION Date: 7 \COIL 6 re I 11 PLEASE DELVER ATTACHED MESSAGE TO: Z-e--f-C`Pt e FAX #: TEL #: Regarding: Number of pages (including cover Remarks: page): 4£9L886ZLZL LPsu H kuLE SO 9 LOZ 60 abed PROT0 bity/ I, • tlr, • ...YON. , ••••••••,..Yinavill trollwit Max +NW br,rne trim Mar Noel tempi' v.' AO t!, Miramar. L ism m.,:a.W.2.ttiat,rat. irrar: M.Priabt IDat ammardar irararammilimatoraniaramitetri iraris 2.0arar bar L Hit II 44, O i irri d to tar limbrutrOwnIkbh I/Its banns, tow ,~ 3110PM,I1,60 etmbecw. Opplanit VW) 801.12.0.70 PROT1 kg 09 2016 0937FII Harry Hach 12129861634 e teetireni A L'422 r e-Y-nernA" PROT8 PROT2 L490L000- fti- V133 FINAL REPORT MANJA.IMWAII"\WAAAI'ml - EPSTEIN, ) D08:01/29/1953 Address:3 w NEW YORK, P: (212) LABORATORIES n FISCH, HARRY 0 HARRY FISCH, M.D. 944 PARK AVENUE New York, NY 10028 Acct I: (C1720-1) Si 0 P: (212) 879-0800 P, JEFFREY Age:63 Y Sex:/1 E 71ST STREET NY 10021 772-9415 S Specimen ID: 105819158 A Date Of Report: 07/23/2016 M Date Collected: 07/20/2016 Time Collected: 08:52 i) Date Received: 07/20/2016 L Time Received: 23:20 C North America Eastern Time C_INICA'_ REPOt: Clinical Abnormalities Suarnary: ;may ra :ortaw ae aoname [ewes. eau ve toots may rot babe aonnat laps muse 'mew tome report) Creatinine 0.62 LO BUN/Creat Ratio Cholesterol 210 HI Triglycerides HDL as % of 13 Chol/HDL Ratio Cholesterol MDC 35.2 HI Hemoglobin A1c 5.9 HI 33.9 HI ALT 42 HI 950 HI HDL CHOL., DIRECT 28 LO 7.5 NON FASTING CHEMISTRY -t"' - .syk'ilitirga,:a.hiata,.. ?,*-V,TirL:T.1-,AAK::£11;02.9);,:n).::::::2447.1AOM4., total Protein 7.0 5.9-8.4 g/dL 6.7 .01/27/2016 ,Albumin 4.7 3.5.5.2 g/dL 4.2 01/27/2916 Globulin 2.3 1.7-3.7 g/dL 2.5 01/27/2016 A/G Ratio 2.0 1.1-2.9 1.7 01/27/2016 Glucose 93 70-99 mg/dL 99 01/27/2016 Sodium 140 135-147 msol/L 141 01/27/2016 rE /W Potassium 4.6 3.5-5.5 esol/L 4.2 Chloride 97 96-188 mmol/L 102 01/27/2016 CO2 24 22-29 msol/L 26 01/27/2016 BUN 21 8-23 mg/dL 22 01/27/2016 Creatinine 0.62 LO 6.89-1.30 mg/dL 1.11 81/27/2016 e-GFR 106 >orm68 mi/min 70 01/27/2816 e-GFR, African American 123 x)rm60 et/min 81 01/27/2016 BUN/Crest Ratio 33.9 HI 10.9-28.0 19.8 01/27/2016 Calcium 9.8 8.6.18.4 mg/dL 9.8 01/27/2016 Uric Acid 7.4 3.4-8.5 mg/dL 7.5 81/27/2016 Iron 96 45-160 ug/dL 75 01/27/2016 Bilirubin, Total 0.6 <1.2 mg/dL 0.5 81/27/2816 LD 286 135-225 U/L 171 01/27/2016 Alk Phas 70 40-156 U/L 43 01/27/2016 AST 32 <40 U/L 29 01/27/2016 Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016 ALT 42 HI <41 U/L 29 01/27/2016 GGTP 19 C:4RDT0',./SClili,R TPT0c- Cholestero 220 HI 10-71 U/L <200 •L 18 143 81/27/2016 ( 01/27/2016 Triglycerides 958 HI ROTE: The result for Triglycerides has been confirmed <150 mg/di 459 HI by repeat analysis. 01/27/2016 HDL CHOL., DIRECT 28 LO >40 mg/dL 24 LO HDL as % of Cholesterol 13 Evaluation: MOVE AVG.(HODERATE RISK) 101/27/2016 >14 X 17 01/27/2016 Chol/HDL Ratio 7.5 <7.4 6.0 81/27/2016 BioReference Laboratories, Inc. 481 tdward H. Ross Dr I Elmwood Park, N2 07407 I (800) 219-5227 lames Heisberger, N.D. Clinical Page 1 of 6 Laboratory Director Printed 07/25/2016 07:01 a6ed 4£91926ZI.a. L-Pstd kueH WdL£SO 9I.62 60 5rY PROT3 9490L000 L2! - V.Ld3 FINAL REPORT J-11,01NA,w1kwl1/44.1%.As e ''W LABORATORIES I ', EPSTEIN, .3 D08:01/20/1953 Address:9 NEW YORK, P: (212) t ...e Ti - s.t. JEFFREY Age:63 Y Sex:M E 71ST STREET NY 10021 772-9416 RISCH, HARRY C New York, NV 10028 T Acct *: (C1720-1) SI P: (212) 879-0800 s Specimen ID: 105819158 A Date Of Report: 87/23/2016 M P l E CLINICAL REPORT a .1 ...40 Evaluation: ABOVE AVG.(MODERATE RISK) $4: :1004440072'111dIR - IWO ' ,r ,iir LDL/HDL Rat10 Can't Calc <3.56 I Can't Calc 01/27/2016 LDL Cholesterol Can't Calc NOTE: Unable to calculate LOL due to a Triglyceride .evel <100 mg/dl. of greater than 400 mg/dL. Can't Calc 01/27/2016 VLDL, CALCULATED Can't Calc 7-32 mg/dL Can't Calc 01/27/2016 Can't Calc: One or more components was outside the measurable range. We are unable to calculate. HENA1OLOGY Wit'-t--; :!;-?:;It•;.:•14: - ,,,:14.4(4n _. 4., ' ...,:it..t. :,142:',:: -31.:.; • ....3LX:S1,"Z WBC 7.79 3.66-11.99 x10(3)/uL 7.12 01/27/2816 RBC 5.18 4.20-5.90 x10(5)/ut 4.96 01/27/2016 HGO 15.4 12.3-17.0 gm/di. 14.3 01/27/2016 HCT 43.8 39.3-52.5 41.3 01/27/2016 MCV 84.6 80.0-100.0 fL 83.3 01/27/2016 MCH 29.7 25.0-34.1 pg 28.8 01/27/2016 MCHC 35.2 HI 29.0-35.0 gm/dL 34.6 01/27/2016 ROW 14.8 10.9-16.9 13.9 01/27/2016 POLYS 45.8 36.0-78.0 49.2 01/27/2016 LYMPH5 39.0 12.0-48.0 36.2 01/27/2016 MON05 8.9 0.0-13.0 7.6 01/27/2016 E05 5.4 0.0-8.0 X 6.5 02/27/2016 BASOS 0.6 0.0-2.0 X 0.4 01/27/2016 IMMATURE GRANULOCYTES 0.0 0.0-1.6 0.1 91/27/2016 PLATELET COUNT 281 144-400 x10(3)/uL 222 01/27/2016 MPV 8.9 NOTE: New reference ranges for WBC and Absolute coun.s 8.2-11.9 fL 9.5 are effective 4/2S/2016. 01/27/2016 PT Ttf? Test Not Performed: Specimen REJECTED for testing due 9.1-11.9 to GROSS LIPEMIA. sec 10.1 01/27/2016 INTR.NORM.RATIO(INR) TNP 2.00-3.00 sec 0.97 10 01/27/2016 PTT TNP 23.6-31.6 26.5 01/27/2016 URINIILYSIS itiglaShiiiiS,azo.L.:-. ,:ilktittabittLT1;$'4' ' Color YELLOW YELLOW, STRAW, AMBER Character CLEAR CLEAR Specific Gravity Ur 1.025 1.003 - 1.030 pH Urine 6.5 5.0 - 8.0 Protein, Urine NEGATIVE NEGATIVE Glucose, Urine NEGATIVE NEGATIVE Ketone, Urine NEGATIVE NEGATIVE Urobilinogen Urine 0.2 0.2 - 1.0 mg/dL sioReference Laboratories, Inc. 481 Edward H. Ross Dr I Elmwood Park, N3 07407 I (800) 2: lames Weisberger, M.D. Clinical Page 2 of 6 9-5227 Printed 07/25/2016 07:01 g abed 4£9L886ZLZ1 LIDsH /URN Wd8£:50 9L02 60 6rr PROT4 6480 L000L8Thild3 Dieference LABORATORIES O gISCH, HARRY c C New York, NY 10028 Acct It: (C1720-1) 51 0 P: (212) 879-0800 P. EPSTEIN, DOB:01/20/1953 Address:, yy e NEW YORK, P: (212) .4 4 JEFFREY Age:63 Y5ex:M E 71ST STREET NY 10021 772-9416 c Specimen ID: 105819158 A Date Of Report: 07/23/2816 '.1 P E Cr_INIC:4•1 REPORT ....Thi ilitZYA•fgOic.i4;:nt Bilirubin, Urine NEGATIVE NEGATIVE eu Blood, Urine NEGATIVE NEGATIVE Nitrites Urine NEGATIVE NEGATIVE Leukocyte Esterase NEGATIVE NEGATIVE Crystals Urine NONE NONE Crystal Amt. Urine NONE NONE WBC, Urine 0-4 0-4 PER HPF RBC, Urine NONE SEEN NONE SEEN PER HPF Epithelial Cells, Ur NONE FEW Cast, Hyaline, Urine 0-4 0-4 PER LPF Cast, Granular, Ur NONE SEEN 0-1 PER LPF Cast, RBC, Urine NONE SEEN 0-1 PER LPF Bacteria, Urine NONE FEW VITCRORTOECCN kigit...,t;ai;V.44-4:"."1 y CULTURE, URINE NO GROWTH SITE: URINE nisciLLPNLcus ,+.?..,*,24:Tifd4W1816.4,L,-,. . NO GROWTH :.."*.'xr - " C ,:' 7.-'," ir/' --" Hemoglobin Alc 5.9 HI HEMOGLOBIN A1c AND eAG REFERENCE RANGES Alc(%) DIABETES CATEGORY* <5.7 Normal (nos 5.7-6.4 Increased risk .>6.5 Consistent Aic(%) eAG(ESTimATED AVERAGE 6 126 7 154 8 103 9 212 10 240 11 269 12 298 'recommended ranges-American Diabetes NOTE: Hemalysis, rare hemoglobin variants and thalavemia <5.7 6.0 HI 101/27/2016 -diabetic) of diabetes with diabetes PLASMA GLUCCGE)(mg/dL) Association(2010) major may affect glycemic results. TSH TNP Test Not Performed: Specimen rejected for testing due hemolysis. 0.178-4.530 uIU/ml. i 1.790 101/27/2016 to moderate or marked Thyroxine(T4) TNP Test Not Performed: Specimen rejected for testing due 4.9-12.9 ug/dL 6.3 101/27/2016 FINAL REPORT BioReference Laboratories, Inc. 481 Edward N. Ross Dr I Elmwood Park, N3 07407 I (800) 2 lames Weisberger, A.D. Clinical Page 3 of 6 -5227 Printed 87/25/2016 07:01 g abed 4£9L886ZLZL LPsY AlleH Wd6E:g0 9LOZ 60 6w PROT5 OSSOL000 1.8Thild3 BioReference LABORATORIES OIscm, HARRY New York, NY 10028 Acct It: (C1720-1) Si P: (212) 879-0800 herolysis. EPSTEIN, 3EFFREY D08:01/20/1953 Age:63 V Sex:M Address:9 E 71ST STREET NEW YORK NY 10021 P: (212) 772-9416 T3 Uptake(T3U) TNP 24.3-39.0 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. FINAL REPORT S A td L F Specimen ID: 105819158 Date Of Report: 07/23/2016 29.3 101/27/2016 THYROXINE, FREE(FT4) TNP 0.80-1.73 ng/dL Test Not Performed: Specimen rejected for testing dut to moderate or marked heaolysis. FREE T4 INDEX TNP 1.5-3.8 T3(THYRONINE), TOTAL TNP 72-180 ng/dL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. PSA Total TNP <4.00 ng/ml. Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 101/27/2016 1.8 101/27/2016 127 01/27/2016 NOTE: The PSA assay should not be the only test used for diagnostic purposes. Additional evaluation using ORE, ultrasound, TUR or similar procedures may be used for this purpose. Predictions of disea e recurrence should not be based solely upon values obtained from serial PSA values obtained on the patient. NOTE: Values obtained with different assay methods or kits cannot be used interchangeably. NOTE: Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. values obtained with different assay methods or kits cannot be used interchangeably. ASSAY INFORMATION: Method ElectrochemilumineSCence IamunOaSSay (Roche Diagnostics). % FREE PSA TNP FREE PSA RISK ASSESSMENT 0.33 T01/27/2016 See Below The probability of prostate cancer for men with non-suspicious DRE results, by age group, using PSA values between 4.000 and 10.080 ng/mL and percent FREE PSA values is sumarized in the table below: BioReference Laboratories, Inc. lames Weisberger, N.D. 481 Edward H. Ross Dr I Elmwood Park, NI 07407 I (800) 2:9-5227 47 161/27/2016 Clinical Page 4 of 6 Printed 07/25/2016 07:01 L abed 4E9LS86ZLZI WSJ £ueH kHOP:SO 9142 60 6ny PROT6 LS801.000laVid3 BioReference ?...-4cSZSI.er LABORATORIES .iEPSTE/N, 9 '1000:01/20/1953 4address:1 NEW YORK P: (21t - ji JEFFREY Ago:63 YSOX:M E 71ST STREET NY 10021 ) 772-9416 FINAL KEPOKI 6 FISCH, HARRY New York, NY 10028 Acct 0: (C1720-1) Si P: (212) 879-0800 5 Specimen ID: 105819158 4 Date Of Report: 07/23/2016 P I F T CLINICAL REPORT OF CANCER. PROSABILIIY %free PSA (50-59 yrs) (60-69 yrs) (>orp yrs) cor.10 49.2% 57.5% 64.5% 11-18 26.9% 33.9% 40.8% 19-25 18.3% 23.9% 29.7% >25 9.1% 12.2% 15.8% 'probability of finding prostate cancer by need e biopsy NOTE: Calculation of percent FREE PSA may not be pos ible when the value for TOTAL PSA is in the low mammal range. These gu delines are for assays performed using the Roche E602 immunoassay syS em.(8/2015;V8.0) TESTOSTERONE, TOT.,S. TNP 193.0-740.0 ng/dL 296.0 101/27/2016 TESTOSTERONE, BIOAVAIL. TNP 72.0-460.0 ng/dL 183.8 01/27/2016 SEX HORM.BIND.GLOB. TNP 10-57 nmol/L 18 01/27/2016 FREE TESTOSTERONE TNP 30.00-150.00 pg/mt 80.18 101/27/2016 LH TNP 1.7-8.6 mIll/ml 6.8 01/27/2016 FSH TNP 1.5-12.4 mIU/mt fl 6.8 01/27/2016 PROLACTIN, SERUM TNP 4.0-15.2 ng/mL 3.0 LO 101/27/2016 lest Not Performed: Specimen rejected for testing due hemolysis. ESTRADIOL INF, 7.02-49.06 pg/ml 48.93 01/27/2016 FIBRINOGEN TNP 176-441 mg/a 276 DIHYDROTESTOSTERONS(7) 146.0 106-719 pg/m1 278.0 101/27/2016 01/27/2016 Reference Intervals for Males age 20 years and above: 106.0-719.0 pg/mL Analysis by High Performance Liquid Chromatography/ TandemMass Spectrometry (LC-MS/MS) (7) Performed by: National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19090 eioeeference Laboratories, Inc. 481 Edward H. Ross Dr I Elmwood Park, Nl 07467 I (800) Jones Weisberger, M.D. Clinical Page 5 of 6 -5227 Printed 07/25/2016 07:01 8 abed VE9L886ZLZL ku8H l'HOVS0 9LOZ 60 find PROT7